Zhou D - Search Results

1

Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes.

Xu C, Zhou Y, Xiao Q, He B, Geng G, Wang Z, Cao B, Dong X, Bai W, Wang Y, Wang X, Zhou D, Yuan T, Huo X, Lai J, Yang H. Xu C, et al. Among authors: zhou y, zhou d. Nat Methods. 2021 May;18(5):499-506. doi: 10.1038/s41592-021-01124-4. Epub 2021 May 3. Nat Methods. 2021. PMID: 33941935

2

Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.

Wang Z, Zhu K, Bai W, Jia B, Hu H, Zhou D, Zhang X, Zhang X, Xie Y, Bourgine MM, Michel ML, Lan K, Deng Q. Wang Z, et al. Among authors: zhou d. J Virol. 2014 Mar;88(5):3004-15. doi: 10.1128/JVI.02756-13. Epub 2013 Dec 26. J Virol. 2014. PMID: 24371056 Free PMC article.

3

Gene therapy for colorectal cancer using adenovirus-mediated full-length antibody, cetuximab.

Xing M, Wang X, Chi Y, Zhou D. Xing M, et al. Among authors: zhou d. Oncotarget. 2016 May 10;7(19):28262-72. doi: 10.18632/oncotarget.8596. Oncotarget. 2016. PMID: 27058423 Free PMC article.

4

Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.

Wu H, Bao Y, Wang X, Zhou D, Wu W. Wu H, et al. Among authors: zhou d. Hum Vaccin Immunother. 2017 Jun 3;13(6):1-9. doi: 10.1080/21645515.2016.1278098. Epub 2017 Jan 27. Hum Vaccin Immunother. 2017. PMID: 28129034 Free PMC article.

5

Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection.

Wang X, Zhou P, Wu M, Yang K, Guo J, Wang X, Li J, Fang Z, Wang G, Xing M, Zhou D. Wang X, et al. Among authors: zhou d, zhou p. NPJ Vaccines. 2020 Jul 9;5(1):57. doi: 10.1038/s41541-020-0206-5. eCollection 2020. NPJ Vaccines. 2020. PMID: 32665862 Free PMC article.

6

A bivalent live-attenuated vaccine candidate elicits protective immunity against human adenovirus types 4 and 7.

Guo J, Zhang Y, Zhang Y, Zhang C, Zhu C, Xing M, Wang X, Zhou D. Guo J, et al. Among authors: zhou d. Emerg Microbes Infect. 2021 Dec;10(1):1947-1959. doi: 10.1080/22221751.2021.1981157. Emerg Microbes Infect. 2021. PMID: 34520320 Free PMC article.

7

Author Correction: Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes.

Xu C, Zhou Y, Xiao Q, He B, Geng G, Wang Z, Cao B, Dong X, Bai W, Wang Y, Wang X, Zhou D, Yuan T, Huo X, Lai J, Yang H. Xu C, et al. Among authors: zhou y, zhou d. Nat Methods. 2022 Feb;19(2):255. doi: 10.1038/s41592-021-01379-x. Nat Methods. 2022. PMID: 34975157 No abstract available.

8

One HA stalk topping multiple heads as a novel influenza vaccine.

Zhou P, Qiu T, Wang X, Yang X, Shi H, Zhu C, Dai W, Xing M, Zhang X, Xu J, Zhou D. Zhou P, et al. Among authors: zhou d. Emerg Microbes Infect. 2024 Dec;13(1):2290838. doi: 10.1080/22221751.2023.2290838. Epub 2024 Jan 22. Emerg Microbes Infect. 2024. PMID: 38044872 Free PMC article.

9

Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway.

Dai W, Xing M, Sun L, Lv L, Wang X, Wang Y, Pang X, Guo Y, Ren J, Zhou D. Dai W, et al. Among authors: zhou d. J Virol. 2024 Dec 17;98(12):e0169924. doi: 10.1128/jvi.01699-24. Epub 2024 Nov 4. J Virol. 2024. PMID: 39494905 Free PMC article.

10

Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models.

Chi Y, Wang X, Yang Y, Zhang C, Ertl HC, Zhou D. Chi Y, et al. Among authors: zhou d. Mol Ther Nucleic Acids. 2014 Nov 4;3(11):e208. doi: 10.1038/mtna.2014.59. Mol Ther Nucleic Acids. 2014. PMID: 25368912 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,261 results

Search Page

Filters